aid: trialspark name: Formation Bio description: 'Formation Bio (formerly TrialSpark, rebranded in December 2023) is a New York-based, tech-driven, AI-native pharmaceutical company co-founded by Ben Liu and Linhao Zhang. Rather than discovering molecules, Formation Bio in-licenses and acquires clinical-stage drug assets and runs them through a proprietary, software- and AI-driven development engine that compresses clinical planning, trial execution and regulatory work. That engine is a suite of internal platforms — Delphi (probability-of-technical-success and value modeling), Atlas (clinical-stage asset screening), Forge (autonomous trial design and scenario evaluation), Apollo (trial execution, study startup, enrollment and closeout), ARK (an AI orchestration layer connecting 80+ internal systems behind one governed interface) and a unified Data Platform spanning trial data, real-world patient data, literature and standardized ontologies. The company raised a $372M Series D led by Andreessen Horowitz with participation from Sanofi, and built Muse, an AI patient-recruitment system, with Sanofi and OpenAI. Formation Bio''s technology is internal-facing: as of this profile the company publishes no public developer portal, API documentation, machine-readable API contract, or client SDKs.' url: https://raw.githubusercontent.com/api-evangelist/trialspark/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enrichment-pipeline specificationVersion: '0.20' created: '2026-07-31' modified: '2026-07-31' image: https://cdn.sanity.io/images/1oav6d5s/production/682b89b26ef34fc9cc89ca7c30f1044d429dab58-5542x8312.jpg?w=1200&h=630&fit=crop&auto=format tags: - Company - Health - Healthcare - Pharmaceuticals - Drug Development - Clinical Trials - Life Sciences - Artificial Intelligence - Biotechnology - Machine Learning apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://www.formation.bio/ - type: About url: https://www.formation.bio/about-us - type: Blog url: https://www.formation.bio/blog - type: Press url: https://www.formation.bio/press - type: Careers url: https://www.formation.bio/careers - type: Contact url: https://www.formation.bio/contact - type: PrivacyPolicy url: https://www.formation.bio/documents/privacy-policy - type: GitHubOrganization url: https://github.com/trialspark - type: LinkedIn url: https://www.linkedin.com/company/formationbio/ - type: Twitter url: https://x.com/formationbio/ - type: YouTube url: https://www.youtube.com/@FormationBio - type: SecondaryMarket url: https://forgeglobal.com/trialspark_stock/ - type: Packages url: packages/trialspark-packages.yml - type: LLMsTxt url: llms/trialspark-llms.txt - type: DomainSecurity url: security/trialspark-domain-security.yml x-enrichment: date: '2026-07-31' status: enriched artifacts_added: 4 pass: local-v1 x-contract-discovery: probed: '2026-07-31' result: none openapi: false graphql: false mcp: false agent_card: false asyncapi: false webhooks: false note: >- Formation Bio publishes no public API. Probed /openapi.json, /openapi.yaml, /swagger.json, /v1/openapi.json, /api-docs, /docs, /redoc and /graphql on www.formation.bio and app.formation.bio; probed the /.well-known/ namespace (security.txt, openid-configuration, oauth-authorization-server, api-catalog, ai-plugin.json, agent-card.json, agent.json) on every resolvable host; resolved api./developers./docs./status./trust./mcp./muse. subdomains (all NXDOMAIN except app., which 404s on every path). The Next.js site answers HTTP 200 with an SPA not-found shell for arbitrary root paths, so a 200 there is not evidence of a document — every candidate was body-checked and every one was the "Oh no!" shell. See well-known/trialspark-well-known.yml for the full probe table. no_wellknown_pointer_reason: >- well-known/trialspark-well-known.yml records an all-404 result; no WellKnown pointer is wired because no well-known document exists.